273 related articles for article (PubMed ID: 19074827)
21. Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.
Frank RT; Edmiston M; Kendall SE; Najbauer J; Cheung CW; Kassa T; Metz MZ; Kim SU; Glackin CA; Wu AM; Yazaki PJ; Aboody KS
PLoS One; 2009 Dec; 4(12):e8314. PubMed ID: 20016813
[TBL] [Abstract][Full Text] [Related]
22. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
[TBL] [Abstract][Full Text] [Related]
23. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
24. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.
Tabatabai G; Frank B; Möhle R; Weller M; Wick W
Brain; 2006 Sep; 129(Pt 9):2426-35. PubMed ID: 16835250
[TBL] [Abstract][Full Text] [Related]
25. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.
Kim SK; Cargioli TG; Machluf M; Yang W; Sun Y; Al-Hashem R; Kim SU; Black PM; Carroll RS
Clin Cancer Res; 2005 Aug; 11(16):5965-70. PubMed ID: 16115940
[TBL] [Abstract][Full Text] [Related]
26. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
[TBL] [Abstract][Full Text] [Related]
27. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.
Ehtesham M; Kabos P; Kabosova A; Neuman T; Black KL; Yu JS
Cancer Res; 2002 Oct; 62(20):5657-63. PubMed ID: 12384520
[TBL] [Abstract][Full Text] [Related]
28. Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo.
Gillespie DL; Flynn JR; Ragel BT; Arce-Larreta M; Kelly DA; Tripp SR; Jensen RL
Methods Mol Biol; 2009; 487():283-301. PubMed ID: 19301653
[TBL] [Abstract][Full Text] [Related]
29. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway.
Imitola J; Raddassi K; Park KI; Mueller FJ; Nieto M; Teng YD; Frenkel D; Li J; Sidman RL; Walsh CA; Snyder EY; Khoury SJ
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18117-22. PubMed ID: 15608062
[TBL] [Abstract][Full Text] [Related]
30. Migration of human neural stem cells toward an intracranial glioma.
Jeon JY; An JH; Kim SU; Park HG; Lee MA
Exp Mol Med; 2008 Feb; 40(1):84-91. PubMed ID: 18305401
[TBL] [Abstract][Full Text] [Related]
31. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
[TBL] [Abstract][Full Text] [Related]
32. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
33. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
[TBL] [Abstract][Full Text] [Related]
34. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
[TBL] [Abstract][Full Text] [Related]
35. Nicotine does not affect stem cell properties requisite for suicide gene therapy against glioma.
Kenmochi H; Yamasaki T; Koizumi S; Sameshima T; Namba H
Neurol Res; 2020 Oct; 42(10):818-827. PubMed ID: 32588772
[TBL] [Abstract][Full Text] [Related]
36. Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
Almiron Bonnin DA; Havrda MC; Lee MC; Liu H; Zhang Z; Nguyen LN; Harrington LX; Hassanpour S; Cheng C; Israel MA
Oncogene; 2018 Feb; 37(8):1107-1118. PubMed ID: 29155422
[TBL] [Abstract][Full Text] [Related]
37. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
Aboody KS; Brown A; Rainov NG; Bower KA; Liu S; Yang W; Small JE; Herrlinger U; Ourednik V; Black PM; Breakefield XO; Snyder EY
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12846-51. PubMed ID: 11070094
[TBL] [Abstract][Full Text] [Related]
38. In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model.
Chien LY; Hsiao JK; Hsu SC; Yao M; Lu CW; Liu HM; Chen YC; Yang CS; Huang DM
Biomaterials; 2011 Apr; 32(12):3275-84. PubMed ID: 21295344
[TBL] [Abstract][Full Text] [Related]
39. The p75 neurotrophin receptor enhances HIF-dependent signaling in glioma.
Tong B; Pantazopoulou V; Johansson E; Pietras A
Exp Cell Res; 2018 Oct; 371(1):122-129. PubMed ID: 30092219
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]